Erin Northington is the Vice President of Emerging Life Sciences at USDM Life Sciences.

Erin leads USDM’s Emerging Life Science division at USDM, which focuses on helping Startup Biotech, Pharma, Medical Device and, most recently, Medical Cannabis and Cannabinoid companies to rapidly establish their regulatory compliance strategies and technologies, accelerate their digital transformation by driving vendor selection and implementation of all Regulated systems, as well as ensuring their cloud strategies are aligned for compliance and commercialization. Erin has over two decades of experience in Life Sciences, GxP Applications, Business Relationship Management,and ProgramManagement. She also has a background in developing IT Roadmaps and Strategy, leading global GxP enterprise-wide cloud and on-premise system implementations and validations, GxP compliance, software auditing, vendor evaluation and management, and process evaluation and improvement. 

Interested in partnering with USDM?

Take the first step towards creating more value with USDM today.

Connect Now

We use cookies to understand how you use our site and improve your experience. This includes personalizing content and advertising. Learn more.